{"title":"Some epidemiologic variables in ovarian carcinoma.","authors":"L. Krain","doi":"10.2307/4594427","DOIUrl":null,"url":null,"abstract":"THE age-adjusted mortality rate from carcinoma of the ovary (primary) ( 175, International Classification of Diseases, 1955 revision) in the United States has increased from 3.1 to 7.6 per 100,000 population for the years 1930-67, partially because of improved diagnostic facilities and increased awareness of the disease (1, 2). The end results data of the National Cancer Institute show that the 5-year survival rate has increased from approximately 24 percent for 1940-49 to 30 percent for 1955-59 for all stages (3, 4). Thus, despite a slight increase in relative survival rates, ovarian cancer mortality continues to rise. This rise must mean that","PeriodicalId":78306,"journal":{"name":"HSMHA health reports","volume":"87 1 1","pages":"56-60"},"PeriodicalIF":0.0000,"publicationDate":"1972-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2307/4594427","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HSMHA health reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2307/4594427","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
THE age-adjusted mortality rate from carcinoma of the ovary (primary) ( 175, International Classification of Diseases, 1955 revision) in the United States has increased from 3.1 to 7.6 per 100,000 population for the years 1930-67, partially because of improved diagnostic facilities and increased awareness of the disease (1, 2). The end results data of the National Cancer Institute show that the 5-year survival rate has increased from approximately 24 percent for 1940-49 to 30 percent for 1955-59 for all stages (3, 4). Thus, despite a slight increase in relative survival rates, ovarian cancer mortality continues to rise. This rise must mean that